|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2007-5-28
|
|
pubmed:abstractText |
CD4 cell count changes in therapy-naive patients were investigated during 7 years of highly active antiretroviral therapy (HAART) in an observational cohort.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1525-4135
|
|
pubmed:author |
pubmed-author:ATHENA, Netherlands National Observational Cohort Study,
pubmed-author:FraserChristopheC,
pubmed-author:GhaniAzra CAC,
pubmed-author:GrasLuukL,
pubmed-author:GriffinJames TJT,
pubmed-author:KesselringAnouk MAM,
pubmed-author:LangeJoep M AJM,
pubmed-author:MiedemaFrankF,
pubmed-author:ReissPeterP,
pubmed-author:de WolfFrankF,
pubmed-author:van SighemArd IAI
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
45
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
183-92
|
|
pubmed:dateRevised |
2007-8-10
|
|
pubmed:meshHeading |
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater.
|
|
pubmed:affiliation |
HIV Monitoring Foundation, Amsterdam, The Netherlands. l.a.gras@amc.uva.nl
|
|
pubmed:publicationType |
Journal Article
|
